Insider · CIK 0002027261
Alastair Garfield
Files at RYTM (RHYTHM PHARMACEUTICALS, INC.). First filing Jul 3, 2025, latest Jul 3, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RYTM: RHYTHM PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 14Weak | RHYTHM PHARMACEUTICALS, INC. | $85k 1,319 shares | -30% | +43% from low-2% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +16,650 | $0.00 | $0 | 16,650 | Feb 13, 2026 |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Stock Options (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Feb 13, 2026 |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +6,663 | - | - | 9,789 | Feb 3, 2026 |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | FTax withholding Common Stock | -2,026 | $108.99 | $221k | 7,763 | Feb 3, 2026 |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -6,663 | $0.00 | $0 | 19,987 | Feb 3, 2026 |
| Jul 1, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +4,445 | - | - | 4,445 | Jul 3, 2025 |
| Jul 2, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,313 | $64.81 | $85k | 3,132 | Jul 3, 2025 |
| Jul 2, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6 | $64.60 | $388 | 3,126 | Jul 3, 2025 |
| Jul 1, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -4,445 | $0.00 | $0 | 13,333 | Jul 3, 2025 |
| Feb 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +26,650 | $0.00 | $0 | 26,650 | Feb 19, 2025 |
| Feb 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Stock Options (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.